rs1262969313
|
CPNE1;RBM12
|
SCHIZOPHRENIA 19
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs781720548
|
CPNE1;RBM12
|
SCHIZOPHRENIA 19
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs17426738
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs17426738
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs17427233
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs17427233
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6058292
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6058292
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060536
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060536
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060540
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060540
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060545
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6060545
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6119636
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6119636
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6121019
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6121019
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6121021
|
CPNE1;RBM12
|
Protein C antigen measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs6121021
|
CPNE1;RBM12
|
Protein C measurement
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.
|
20802025 |
2010 |
rs781720548
|
CPNE1;RBM12
|
Nonorganic psychosis
|
|
0.010 |
GeneticVariation |
BEFREE |
We replicated the association in a Finnish family in which a second RBM12 truncating mutation (c.2532delT) segregates with psychosis (P = 0.020). c.2377G>T is not fully penetrant for psychosis; however, we found that carriers unaffected by psychosis resemble patients with schizophrenia in their non-psychotic psychiatric disorder and neuropsychological test profile (P = 0.0043) as well as in their life outcomes (including an increased chance of receiving disability benefits, P = 0.011).
|
28628109 |
2017 |
rs781720548
|
CPNE1;RBM12
|
Psychotic Disorders
|
|
0.010 |
GeneticVariation |
BEFREE |
We replicated the association in a Finnish family in which a second RBM12 truncating mutation (c.2532delT) segregates with psychosis (P = 0.020). c.2377G>T is not fully penetrant for psychosis; however, we found that carriers unaffected by psychosis resemble patients with schizophrenia in their non-psychotic psychiatric disorder and neuropsychological test profile (P = 0.0043) as well as in their life outcomes (including an increased chance of receiving disability benefits, P = 0.011).
|
28628109 |
2017 |
rs781720548
|
CPNE1;RBM12
|
Schizophrenia
|
|
0.010 |
GeneticVariation |
BEFREE |
We replicated the association in a Finnish family in which a second RBM12 truncating mutation (c.2532delT) segregates with psychosis (P = 0.020). c.2377G>T is not fully penetrant for psychosis; however, we found that carriers unaffected by psychosis resemble patients with schizophrenia in their non-psychotic psychiatric disorder and neuropsychological test profile (P = 0.0043) as well as in their life outcomes (including an increased chance of receiving disability benefits, P = 0.011).
|
28628109 |
2017 |
rs781720548
|
CPNE1;RBM12
|
Mental disorders
|
|
0.010 |
GeneticVariation |
BEFREE |
We replicated the association in a Finnish family in which a second RBM12 truncating mutation (c.2532delT) segregates with psychosis (P = 0.020). c.2377G>T is not fully penetrant for psychosis; however, we found that carriers unaffected by psychosis resemble patients with schizophrenia in their non-psychotic psychiatric disorder and neuropsychological test profile (P = 0.0043) as well as in their life outcomes (including an increased chance of receiving disability benefits, P = 0.011).
|
28628109 |
2017 |